跳至主要内容
临床试验/CTRI/2021/04/032979
CTRI/2021/04/032979已完成未知

Pharmaceutical Development of Jivantyadi Yamaka into Malahara and their Comparative Clinical Efficacy in Ekakustha (Psoriasis)

Government Ayurved Hospital Vadodara0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with all forms of Ekakushtha (Psoriasis) with classical signs & symptoms of Ekakushtha (Psoriasis)
  • All type of psoriasis will be included
  • Less than 20 % involved area according to PASI guidelines

排除标准

  • More than 20 % involved area according to PASI guidelines
  • Age <18yrs and >60yrs.
  • Pregnant women and lactating mother
  • Uncontrolled Diabetes Mellitus & Hypertension
  • Any other serious systemic illness like AIDS, Malignancy etc
  • ââ?¬Â¢Patients who are not willing to be included in the study

研究者

发起方
Government Ayurved Hospital Vadodara

相似试验